Infectious Disease Immunoassay Market

Infectious Disease Immunoassay Market by Product & Services (Reagents and kits, Analysers & Software and Services), Platform (CLIA, FIA, CI, RIA), Specimen Type, Disease (Hepatitis, HIV, CT/NG, HPV, TB, Influenza) & End User - Global Forecast to 2023

Report Code: UC 1961 Jan, 2019, by marketsandmarkets.com

The global infectious disease immunoassay market is expected to reach USD 2,233.0 million by 2023 from USD 1,642.5 million in 2018, growing at a CAGR of 6.3%. Increasing incidence of chronic and infectious diseases; technological advancements in immunoassay instruments and the introduction of novel automated systems; growth in biotechnology and biopharmaceutical industries; increasing adoption of immunoassay-based point-of-care testing and rapid testing are some of the major factors driving the growth of the global infectious disease immunoassay market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.

North America dominates the infectious disease immunoassay market with the North America accounted major market share in 2017. Established healthcare infrastructure; and technological advancements in immunoassay instrumentation are some of the major driving factors driving the growth of this market in North America. The Asian infectious disease immunoassay market is poised to grow at the highest CAGR during the forecast period owing to improving healthcare infrastructure and rising awareness about advanced point-of-care diagnostics among people in the region. The rising focus of prominent players on the Asian infectious disease immunoassay market is another factor driving its growth. Furthermore, emerging countries such as India and China provides immense growth opportunities to the infectious disease immunoassay manufacturers.

Prominent players in the infectious disease immunoassay market are Abbott Laboratories, Inc., Siemens AG, Beckman Coulter, Inc., Sysmex Corporation, Biomerieux Sa, Ortho Clinical Diagnostics, Inc., DiaSorin, QIAGEN N.V, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Agilent Technologies.

Scope of the Report

This research report covers the global suture anchor device market by method; product & services; platform; specimen type; disease type; end user; and geography.

Infectious Disease Immunoassay Market, by Product Type

  • Reagents & Kits
    • ELIZA
    • Rapid Tests
    • ELISPOT
    • Western Blot
    • Other reagents and kits
  • Analyzers
    • Open-ended systems
    • Closed-ended systems
  • Software And Services

Infectious Diseases Immunoassay Market, BY Platform

  • Chemiluminescence Immunoassay (CLIA)
  • Fluorescence Immunoassay (FIA)
  • Colorimetric Immunoassay (CI)
  • Radioimmunoassay (RIA)
  • Other Platfoms

Infectious Disease Immunoassay market, by Specimen Type

  • Blood
  • Saliva
  • Urine
  • Other

Infectious Diseases Immunoassay market, by Disease type

  • Hepatitis
  • hiv
  • ct/ng
  • hais
  • HPV
  • TB
  • Influenza
  • Other

Infectious Diseases Immunoassay market, by End User

  • Hospitals and Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies & Cros
  • Academic & Research Laboratories
  • Other End Users

Infectious Disease Immunoassay market, BY region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest Of Europe (Roe)
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1 Introduction
    1.1 Objective of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Study
    1.4 Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Crackdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data Points Taken From Secondary Sources
           2.3.2 Key Data Points Taken From Primary Sources
    2.4 Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Restraints
           5.2.3 Opportunities
           5.2.4 Challenges

6 Infectious Diesease Immunoassay Market, By Products and Services
    6.1 Introduction
    6.2 Reagents & Kits
           6.2.1 Elisa
           6.2.2 Rapid Tests
           6.2.3 Elispot
           6.2.4 Western Blot
           6.2.5 Other Reagents and Kits
    6.3 Analyzers
           6.3.1 Open-Ended Systems
           6.3.2 Close-Ended Systems
    6.4 Software & Services

7 Infectious Diesease Immunoassay Market, By Platform
    7.1 Introduction
    7.2 Chemiluminescence Immunoassay (CLIA)
    7.3 Fluorescence Immunoassay (FIA)
    7.4 Colorimetric Immunoassay (CI)
    7.5 Radioimmunoassay (RIA)
    7.6 Other Platforms

8 Infectious Diesease Immunoassay Market, By Specimen Type
    9.1 Introduction
    9.2 Blood
    9.4 Saliva
    9.5 Urine
    9.6 Other Specimens

9 Infectious Diesease Immunoassay Market, By Disease Type
    9.1 Introduction
    9.2 Hepatitis
    9.4 HIV
    9.5 CT/NG
    9.6 HAIS
    9.7 HPV
    9.8 TB
    9.9 Influenza
    9.10 Others

10 Infectious Diesease Immunoassay Market, By End User
     10.1 Introduction
     10.2 Hospitals and Clinical Laboratories
     10.3 Pharmaceutical & Biotechnology Companies and Cros
     10.4 Research and Academic Laboratories
     10.5 Other End Users

11 Infectious Diesease Immunoassay Market, By Region
     11.1 Introduction
     11.2 North America
             11.2.1 US
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 UK
             11.3.3 France
             11.3.6 Rest of Europe (RoE)
     11.4 Asia Pacific
             11.4.1 China
             11.4.2 India
             11.4.3 Japan
             11.4.4 Rest of Asia Pacific
     11.5 Latin America
     11.6 Middle East and Africa

12 Competitive Landscape
     12.1 Introduction
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends

13 Company Profiles*
     13.1 Introduction
     13.2 Abbott Laboratories, Inc.
     13.3 Siemens AG 
     13.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) 
     13.5 Sysmex Corporation 
     13.6 Biomérieux Sa 
     13.7 Ortho Clilnical Diagnostics, Inc. 
     13.8 Diasorin
     13.9 Qiagen N.V. 
     13.10 Thermo Fisher Scientific, Inc. 
     13.11 Becton, Dickinson and Company
     13.12 Bio-Rad Laboratories, Inc.
     13.13 Agilent Technologies


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1961
Published ON
Jan, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Infectious Disease Immunoassay Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved